Dendritic cell vaccination for glioblastoma multiforme: review with focus on predictive factors for treatment response

Dendritic cell vaccination for glioblastoma multiforme: review with focus on predictive factors for treatment response

Joost Dejaegher,1 Stefaan Van Gool,2 Steven De Vleeschouwer1 1Department of Neurosciences, 2Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium Abstract: Glioblastoma multiforme (GBM) is the most common and most aggressive type of primary brain cancer. Since median overall surviva...

Full description

Bibliographic Details
Main Authors: Dejaegher J, Van Gool S, De Vleeschouwer S
Format: Article
Language:English
Published: Dove Medical Press 2014-03-01
Series:ImmunoTargets and Therapy
Subjects:
Glioblastoma multiforme– Immunotherapy – Dendritic cell vaccination – personalized medicine
Online Access:https://www.dovepress.com/dendritic-cell-vaccination-for-glioblastoma-multiforme-review-with-foc-peer-reviewed-article-ITT

Internet

https://www.dovepress.com/dendritic-cell-vaccination-for-glioblastoma-multiforme-review-with-foc-peer-reviewed-article-ITT

Similar Items